Achieve Life Sciences Stock Price. Everything You Need To Know About The Achieve Life Sciences Stock!
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company based in Seattle, Washington, that specializes in developing and commercializing cytisinicline, a naturally occurring, plant-based alkaloid, for smoking cessation. Cytisinicline has a unique, dual-acting mechanism of action that is both agonistic and antagonistic, with a high affinity for alpha-4 beta-2, nicotinic acetylcholine receptors in the brain, helping to reduce nicotine cravings, withdrawal symptoms, and the reward and satisfaction associated with smoking.
As an emerging stock in the pharmaceutical industry, it’s important to stay up-to-date with Achieve Life Sciences and their progress in bringing cytisinicline to market. The stocks share price today may not reflect the full potential of this innovative product candidate, and investors should consider conducting research to understand the potential impact of cytisinicline on the market cap of the smoking cessation industry.
For those seeking to quit smoking, cytisinicline could be a viable alternative to prescription drugs or over-the-counter products. While it’s essential to note that this is not financial advice, understanding the potential of Achieve Life Sciences and their innovative product candidate could be an essential step in diversifying an investment portfolio. By keeping an eye on premarket fluctuations and market trends, investors can stay informed about Achieve Life Sciences and its promising future in the smoking cessation industry.
Achieve Life Sciences Stock Price. Everything You Need To Know About The Achieve Life Sciences Stock! performance
- Employees 16
- Company HQ Seattle
- Website http://achievelifesciences.com/
- ACHV Asset Type Common Stock
- ACHV Market Capitalization 156.9M
- Earnings Per Share -1.5
- Dividends Per Share None
- Dividend Date 2020-07-31
- Quarterly Earnings Growth 0
Investing in the Achieve Life Sciences stock from Malaysia, Thailand, Indonesia, and Vietnam can be a smart move for retail investors looking to diversify their portfolios. Achieve Life Sciences is a pharmaceutical company focused on developing and commercializing therapies for nicotine addiction. With its innovative and potentially life-changing products, Achieve Life Sciences has garnered the attention of investors seeking opportunities in the healthcare sector. To invest in Achieve Life Sciences, investors from Malaysia, Thailand, Indonesia, and Vietnam can leverage the Zorion investment platform. Zorion provides a user-friendly interface that allows investors to easily navigate through the available stock options. Additionally, the platform offers investment insights and recommendations specific to Achieve Life Sciences, enabling investors to make informed decisions. To further enhance their investment knowledge, retail investors can access educational materials and resources available on Zorion. These materials provide valuable information about Achieve Life Sciences, its products, financial performance, and the overall healthcare industry landscape. By utilizing the expertise and resources offered by Zorion, retail investors from Malaysia, Thailand, Indonesia, and Vietnam can confidently invest in Achieve Life Sciences and potentially benefit from its growth and success in the pharmaceutical sector. Start your investment journey today and capitalize on the opportunities presented by Achieve Life Sciences with Zorion.
